Login / Signup

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure.

Isis G Montalvo-OcotoxtleGustavo Rojas-VelascoOlivia Rodríguez-MoralesMinerva Arce-FonsecaLuis Augusto Baeza-HerreraArturo Arzate-RamírezGabriela Meléndez-RamírezDaniel Manzur-SandovalMayra L Lara-RomeroAntonio Reyes-OrtegaPatricia Espinosa-GonzálezErika Palacios-Rosas
Published in: Journal of clinical medicine (2022)
Chagas cardiomyopathy (CC), caused by the protozoan Trypanosoma cruzi , is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 200,000 deaths by 2025. The World Health Organization (WHO) considers Chagas disease (CD) as a Neglected Tropical Disease (NTD), which must be acknowledged and detected in time, as it remains a clinical and diagnostic challenge in both endemic and non-endemic regions and at different levels of care. The literature on CC was analyzed by searching different databases (Medline, Cochrane Central, EMBASE, PubMed, Google Scholar, EBSCO) from 1968 until October 2022. Multicenter and bioinformatics trials, systematic and bibliographic reviews, international guidelines, and clinical cases were included. The reference lists of the included papers were checked. No linguistic restrictions or study designs were applied. This review is intended to address the current incidence and prevalence of CD and to identify the main pathogenic mechanisms, clinical presentation, and diagnosis of CC.
Keyphrases
  • trypanosoma cruzi
  • heart failure
  • risk factors
  • healthcare
  • systematic review
  • climate change
  • palliative care
  • randomized controlled trial
  • quality improvement